Dr. Jeffrey R. Jay, M.D. »

Anavex Life Sciences shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Anavex Life Sciences (AVXL) shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Anavex Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Anavex Life Sciences held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anavex Life Sciences by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.6M 521k 3.07

More positions owned by Dr. Jeffrey R. Jay, M.D.

Apogee Therapeutics (APGE)
Vor Biopharma Com New (VOR)
Zura Bio Class A Ord Shs (ZURA)
Amylyx Pharmaceuticals (AMLX)
Immunitybio Put Option (IBRX)
Nektar Therapeutics Com New (NKTR)
Sol-gel Technologies Shs New (SLGL)
Alumis (ALMS)
Bright Minds Biosciences Com New (DRUG)
Annexon (ANNX)
Kalvista Pharmaceuticals (KALV)
Immunovant (IMVT)
Jade Biosciences Com New (JBIO)
Contineum Therapeutics Cl A (CTNM)
Zenas Biopharma (ZBIO)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Anavex Life Sciences

BlackRock
Vanguard Group
State Street Corporation
Vanguard Capital Management
Two Sigma Investments
Geode Capital Management
Susquehanna International
Citadel Advisors
Summit Financial
Bank of America Corporation
Goldman Sachs Group
Vanguard Portfolio Management
AQR Capital Management
Northern Trust
Jane Street

View all funds holding Anavex Life Sciences